» Articles » PMID: 21756310

Prevalence of Target Organ Damage in Hypertensive Subjects Attending Primary Care: C.V.P.C. Study (epidemiological Cardio-vascular Study in Primary Care)

Overview
Journal BMC Fam Pract
Publisher Biomed Central
Date 2011 Jul 16
PMID 21756310
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Except for the established risk factors, presence of target organ damage has an important role in the treatment of hypertensive subjects. The aim of the present study was to estimate the prevalence of target organ damage in primary care subjects.

Methods: This multi-centre, cross-sectional survey of 115 primary care physicians recruited 1095 consecutive subjects with hypertension: 611 men (55.8%); and 484 women (44.2%). A detailed history for the presence of cardiovascular disease and a thorough clinical examination was performed to each subject.

Results: Of the total study population, 44.5% (n = 487) had target organ damage (33.0% had left ventricular hypertrophy, 21.8% increased carotid intima media thickness, 11.0% elevated plasma creatinine levels and 14.6% microalbuminuria). Target organ damage was more prevalent in males than in females (P = 0.05). In addition, males had more often increased carotid intima media thickness than females (P = 0.009). On the contrary, females had more often microalbuminuria (P = 0.06) than males. No differences were observed between the two genders regarding left ventricular hypertrophy (P = 0.35) and elevated plasma creatinine levels (P = 0.21). Logistic regression analysis showed associations between target organ damage and dyslipidemia (P < 0.001), presence of metabolic syndrome (P = 0.005), diabetes (P < 0.001) and coronary artery disease (P < 0.001).

Conclusion: A significant proportion of hypertensive subjects in primary care had documented associated target organ damage, with left ventricular hypertrophy being the most prevalent target organ damage.

Citing Articles

High Rates of Undiagnosed Target Organ Damage Among Adults with Elevated Blood Pressure or Diabetes Mellitus in a Community-Based Survey in Lesotho.

Firima E, Gonzalez L, Khan M, Manthabiseng M, Sematle M, Bane M J Epidemiol Glob Health. 2023; 13(4):857-869.

PMID: 37883005 PMC: 10686968. DOI: 10.1007/s44197-023-00158-5.


Gender Difference of Blood Pressure Control Rate and Clinical Prognosis in Patients With Resistant Hypertension: Real-World Observation Study.

Joo H, Yum Y, Kim Y, Son J, Kim S, Choi S J Korean Med Sci. 2023; 38(16):e124.

PMID: 37096308 PMC: 10125792. DOI: 10.3346/jkms.2023.38.e124.


Editorial: The importance of the central hemodynamic in the cardiovascular diseases development.

Vilela-Martin J, Forcada P Front Cardiovasc Med. 2022; 9:1036440.

PMID: 36299871 PMC: 9589445. DOI: 10.3389/fcvm.2022.1036440.


Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community.

Vasan R, Song R, Xanthakis V, Beiser A, DeCarli C, Mitchell G Hypertension. 2022; 79(3):505-515.

PMID: 35138872 PMC: 8849561. DOI: 10.1161/HYPERTENSIONAHA.121.18502.


Epidemiology of hypertensive heart disease in Poland: findings from the Global Burden of Disease Study 2016.

Miazgowski T, Kopec J, Widecka K, Miazgowski B, Kaczmarkiewicz A Arch Med Sci. 2021; 17(4):874-880.

PMID: 34336015 PMC: 8314396. DOI: 10.5114/aoms.2019.85222.


References
1.
Kotsis V, Stabouli S, Toumanidis S, Papamichael C, Lekakis J, Germanidis G . Target organ damage in "white coat hypertension" and "masked hypertension". Am J Hypertens. 2008; 21(4):393-9. DOI: 10.1038/ajh.2008.15. View

2.
Navarro J, Redon J, Cea-Calvo L, Lozano J, Fernandez-Perez C, Bonet A . Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press. 2007; 16(1):20-7. DOI: 10.1080/08037050701217817. View

3.
Peer N, Steyn K, Dennison C, Levitt N, Nyo M, Nel J . Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study. Am J Hypertens. 2008; 21(8):896-902. DOI: 10.1038/ajh.2008.210. View

4.
Lozano J, Redon J, Cea-Calvo L, Fernandez-Perez C, Navarro J, Bonet A . [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study]. Rev Esp Cardiol. 2006; 59(2):136-42. View

5.
Cuspidi C, Valerio C, Giudici V, Negri F, Sala C, Zanchetti A . Metabolic syndrome and multiple organ damage in essential hypertension. Blood Press. 2008; 17(4):195-203. DOI: 10.1080/08037050802431390. View